BERLIN & COPENHAGEN--(BUSINESS WIRE)--MyoPax has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for its regenerative cell therapy in Exstrophy-Epispadias Complex ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results